您的位置: 首页 > 农业专利 > 详情页

SUBSTANCE AGONISTE SÉLECTIVE DU RÉCEPTEUR EP4 POUR LE TRAITEMENT DU CANCER
专利权人:
RAQUALIA PHARMA INC
发明人:
TAKE, YUKINORI,KOIZUMI, SHINICHI,OKUMURA, TAKAKO,NONOMURA, KAZUHIKO
申请号:
EP10767106
公开号:
EP2422779A4
申请日:
2010.04.22
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
This invention provides a medicament for the treatment of cancer, which cause a reduction of cancer. This invention relates to use of a compound which has inhibitory activities against prostaglandin E2 receptor (EP4 receptor) and is represented by the following general formula (I), (II), (III), or (IV), or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt for the manufacture of a medicament for the treatment of cancer. The invention relates to a method for treatment of cancer comprising administering the compound or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt to humans or animals. The compound or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition may be used in combination with one or more second active agents.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充